Physicians, basic and clinical researchers, healthcare practitioners, patient advocates, caregivers, nurses and community stakeholders are invited to attend. Among the many presenters, Massimo Cristofanilli, MD, FACP, Northwestern University (president of IBC International Consortium); Naoto Ueno, MD, PhD, FACP, MD Anderson IBC Center; and Beth Overmoyer, MD, Dana-Farber Cancer Institute will also speak during the first session: Global Partnership In Clinical Management of IBC. Wendy Woodward, MD, PhD, MD Anderson Cancer Center, will present in the second session: Research Challenges and Opportunities in IBC. In addition, the program will include a conversation cafe style session: Working with Advocates and Community Partners.

Led by Gayathri Devi, PhD, and Paul Kelly Marcom, MD, The Duke Consortium for Inflammatory Breast Cancer is a multidisciplinary center of research innovation and clinical excellence that is focused on understanding, preventing, and treating inflammatory breast cancer through collaboration with our local, national and international partners. It's mission is to understand the challenges faced by patients and caregivers with this highly aggressive and often misdiagnosed type of breast cancer. Compared with other types of breast cancer, inflammatory breast cancer has a unique presentation and tends to be diagnosed at a younger age. African Americans are disporportionately at a higher risk of developing aggressive inflammatory breast cancer with poor outcomes.

Duke Cancer Center North Durham

Duke Surgical Oncology at North Duke Street

Duke Adult Bone Marrow Transplant Clinic

Connect With Us

Ways To Give

Duke Cancer Institute constellates the world-class resources of Duke University, Duke Health and the Duke Comprehensive Cancer Center into a collaborative powerhouse. We are poised to drive a paradigm shift in the way long-established cancer centers and institutes have been waging this war.